Treatment of chronic hepatitis C infection with peginterferons plus ribavirin

Seminars in Liver Disease
M W Fried, Stephanos J Hadziyannis

Abstract

Interferon monotherapy provided the first hope for patients with chronic hepatitis C that the virus could be permanently eradicated. An important development in treating this disease was the recognition that the effects of interferon could be greatly enhanced by combining it with ribavirin, a nucleoside analogue. This combination regimen essentially doubled the sustained virological response rates seen with interferon alone. Recently, modified forms of interferon have been developed that-when used in combination with ribavirin-demonstrate even better efficacy. Thus, peginterferon alfa-2a (Hoffman La-Roche, Nutley, NJ) and peginterferon alfa-2b (Schering-Plough, Kenilworth, NJ) are the latest innovations for the treatment of chronic hepatitis C. The addition of a polyethylene glycol molecule to the native interferon protein favorably alters the pharmacokinetic profile, allowing for once-weekly administration, and leads to superior efficacy compared to standard interferon preparations. This article reviews the data from clinical trials of peginterferon alfa-2a and peginterferon alfa-2b.

Citations

May 25, 2007·Current Psychiatry Reports·Brian Keefe
May 24, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gregory M Asnis, Richard De La Garza
Nov 3, 2009·Nature Reviews. Gastroenterology & Hepatology·Ka-Kit Li, James Neuberger
Jan 7, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vincent SorianoStefan Zeuzem
Jun 10, 2011·The Journal of Antimicrobial Chemotherapy·Vincent SorianoPablo Barreiro
Jan 1, 2013·Nucleic Acids Research·Sumangala ShettyMihaela Rita Mihailescu
Mar 2, 2013·PloS One·Edward CoulstockAdam Walker
Aug 10, 2007·Expert Opinion on Investigational Drugs·Julie SheldonVincent Soriano
Mar 7, 2008·Expert Opinion on Emerging Drugs·Vincent SorianoPablo Barreiro
Oct 29, 2011·Clinics in Liver Disease·Hui-Hui Tan, Paul Martin
May 24, 2011·Bioorganic & Medicinal Chemistry Letters·Michael O ClarkeChoung U Kim
Jul 20, 2010·Patient Education and Counseling·Erik J GroesslSamuel B Ho
Apr 24, 2007·Virus Research·Juan CristinaGonzalo Moratorio
Jan 29, 2008·Journal of Viral Hepatitis·H YuS van Drunen Littel-van den Hurk
Jun 10, 2010·Journal of Viral Hepatitis·E J GroesslS B Ho
Sep 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Simone SusserChristoph Sarrazin
Sep 17, 2005·Immunobiology·Gyongyi Szabo, Angela Dolganiuc
Apr 24, 2012·Journal of Hepatology·Erik J GroesslSteven M Asch
Nov 30, 2010·Journal of Hepatology·Christoph SarrazinThomas Berg
Dec 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Benjamin M WohlAlexander N Zelikin
Mar 1, 2013·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Erik J GroesslAllen L Gifford
May 19, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ziping YangFrancis L S Tse
Aug 31, 2006·Journal of Clinical Gastroenterology·Paul H HayashiBruce R Bacon
Mar 14, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jason P SmithJonathan D Kaunitz
May 6, 2015·World Journal of Hepatology·Natalia EcheverríaPilar Moreno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.